Patented Technology · FDA 510(k) Submission: Q2 2026

Form 211 Filed · OTC Markets

The problem isn't the treatment. It's how healthcare is designed.

Hyperbaric oxygen therapy is FDA-cleared for 14 conditions. Most patients still can't access it consistently.

See How This Fits Your Practice Schedule an Introductory Call

Get a 15-minute overview of clinical integration and implementation timelines

500,000+ physician practices. Fewer than 1,400 hyperbaric facilities.

The access gap represents an infrastructure transformation opportunity.

RxAir360 vertical hyperbaric chamber prototype - latest design iteration

Prototype of the RxAir360 Vertical Monoplace Hyperbaric Chamber — currently in premarket testing and pending FDA 510(k) clearance.

Find Your Path

How Would You Like to Explore RxAir360?

Select the role that best describes you. Each path is built around your specific questions.

Two healthcare workers stand in a medical room next to a large blue hyperbaric oxygen chamber.
For Physicians

Integrate HBOT Into Your Practice

A practical overview of clinical integration, workflow design, and what implementation actually looks like.

  • Fits standard exam rooms — no renovation required
  • Designed for outpatient clinical workflows
  • Physician-led protocols with trained staff support
  • Pending FDA 510(k) clearance
Explore the Physician Overview

See how this fits into your existing practice

Indian technician in microchip factory testing silicon wafer batches with tablet control app
For Investors

Build the Infrastructure of Modern Medicine

Learn how RxAir360 is approaching one of healthcare's most underserved access gaps.

  • Large, underserved U.S. market
  • Two issued U.S. patents
  • Scalable physician adoption model
  • OTC Markets: Form 211 filed
View Investor Overview

For accredited and qualified investors

Happy mature man communicating with a doctor in waiting room at the clinic
For Patients & Families

Learn About Hyperbaric Oxygen Therapy

Understand how HBOT works, what conditions it addresses, and how to talk to your doctor about it.

  • 14 FDA-cleared indications
  • 95+ areas of clinical research
  • Administered in a physician's office
  • Non-invasive, no surgery required
Explore HBOT Basics

Information for patients, caregivers, and advocates

The Physician Access Gap

U.S. Physician Practices 500,000+
Hyperbaric Treatment Facilities Fewer than 1,400

When treatment exists but doesn't reach patients, the issue isn't clinical—it's structural.

A Pattern Repeating Across Healthcare

Dialysis

Once hospital-based

7,500+ outpatient centers

Imaging

Once hospital radiology

6,900+ freestanding facilities

Surgery

Once hospital ORs

6,300+ ambulatory surgery centers

Hyperbaric Medicine

Still largely hospital-based

Fewer than 1,400 facilities

When healthcare infrastructure moves closer to patients, access expands and markets grow. Hyperbaric medicine is entering that same transition.

A Founder's Perspective

"If hyperbaric oxygen therapy has been clinically recognized for decades, why does the United States still lack the infrastructure needed to make it broadly accessible?"

— Diallo M. Watts, Sr., Founder & CEO

Read the Full Founder's Letter

Built With Clinical and Engineering Leadership

Clinical Leadership

Dr. Jeffrey Niezgoda – former president APWCA/ACHM

Dr. Tyler Sexton – President, American College of Hyperbaric Medicine

Manufacturing

Electroimpact – precision engineering partner supporting Boeing and Airbus commercial aircraft programs

Intellectual Property

Two issued U.S. patents covering the vertical monoplace hyperbaric chamber design

Regulatory Pathway

FDA 510(k) submission targeted Q2 2026

Designed to ASME PVHO-1, IEC 60601-1, and NFPA 99 standards

Our Journey

Innovation in Progress

2023–2026

Engineering & Regulatory Development

  • Patent secured for vertical chamber design
  • Prototype development completed
  • Premarket testing underway

2026

510(k) Clearance Submission

  • FDA 510(k) submission in progress
  • Manufacturing scale-up preparation
  • Leasing infrastructure development

2026

Market Launch

  • Texas market deployment
  • RxAir Capital leasing launch

2027–2028

Regional & National Expansion

  • Florida and high-demand markets
  • Nationwide rollout

For informational purposes only. The RxAir360 chamber is not yet cleared for clinical use.